Lead full lifecycle of divestment projects from strategy development to execution
Coordinate cross-functional teams of internal experts and external advisors for divestments
Identify and evaluate acquisition targets aligned with Perrigo’s M&A strategy
Source opportunities using external networks, strategic partners, and tools (including AI)
Build and maintain relationships across global consumer health and OTC pharma industry
Manage transactions from due diligence through deal signing, closing, and integration planning
Collaborate with finance, legal, regulatory, supply chain, commercial teams and external advisors to drive execution
Support preparation, negotiation, and execution of licensing agreements and strategic partnerships
Partner with Scientific Affairs and Rx-to-OTC switch team to strengthen product portfolio
Conduct targeted market analyses, competitor assessments, and develop competitor profiles
Provide actionable insights to inform corporate strategy and M&A pipeline
Requirements
Typically a Bachelor's degree in Business, Finance, Economics, Life Sciences, or a related field; advanced degree (MBA or equivalent) preferred
10+ years of relevant experience in M&A, Business Development, Investment Banking, or Management Consulting, ideally within the pharmaceutical, consumer health, or consumer goods industries
Strong financial modelling, valuation, and analytical skills
Working knowledge of legal, IP, regulatory, and supply chain considerations in consumer health/OTC pharma is a plus
Demonstrated ability to thrive in a matrixed, fast-paced, and cross-functional environment
Exceptional communication, negotiation, and interpersonal skills, with the ability to influence stakeholders at all levels
Fluent in English; additional languages are a plus
Highly self-motivated, results-oriented, and capable of working independently while fostering team collaboration
Cultural sensitivity and ability to build strong relationships in a global business environment